Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Por Merryman, Reid W., Armand, Philippe, Wright, Kyle T., Rodig, Scott J.
Publicado no Blood Adv (2017)

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

Por Sasaki, Takaaki, Rodig, Scott J., Chirieac, Lucian R., Jänne, Pasi A.
Publicado em 2010

Sphingosine-1-Phosphate Receptor 1 in Classical Hodgkin Lymphoma: Assessment of Expression and Role in Cell Migration

Por Kluk, Michael J., Ryan, Kieran, Wang, Bonnie, Zhang, Guoqi, Rodig, Scott J., Sanchez, Teresa
Publicado em 2013

Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo

Por Hao, Yansheng, Chapuy, Bjoern, Monti, Stefano, Sun, Heather H., Rodig, Scott J., Shipp, Margaret A.
Publicado em 2014

Genomic instability resulting from Blm-deficiency compromises development, maintenance, and function of the B cell lineage

Por Babbe, Holger, McMenamin, Jennifer, Hobeika, Elias, Wang, Jing, Rodig, Scott J., Reth, Michael, Leder, Philip
Publicado em 2009

ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas

Por Sholl, Lynette M., Sun, Heather, Butaney, Mohit, Zhang, Chengsheng, Lee, Charles, Jänne, Pasi A., Rodig, Scott J.
Publicado em 2013

Quantitative Immunofluorescence Reveals the Signature of Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma

Por Bogusz, Agata M., Baxter, Richard H. G., Currie, Treeve, Sinha, Papiya, Sohani, Aliyah R., Kutok, Jeffery L., Rodig, Scott J.
Publicado no Clin Cancer Res (2012)

Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated with PDCD1LG2 Copy Gain

Por Shi, Min, Roemer, Margaretha GM, Chapuy, Bjoern, Liao, Xiaoyun, Sun, Heather, Pinkus, Geraldine S., Shipp, Margaret A., Freeman, Gordon J., Rodig, Scott J.
Publicado no Am J Surg Pathol (2014)

SIRPα and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen

Por Ogembo, Javier Gordon, Milner, Danny A., Mansfield, Keith G., Rodig, Scott J., Murphy, George F., Kutok, Jeffery L., Pinkus, Geraldine S., Fingeroth, Joyce D.
Publicado em 2012

Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas

Por Gostissa, Monica, Bianco, Julia M., Malkin, Daniel J., Kutok, Jeffery L., Rodig, Scott J., Morse, Herbert C., Bassing, Craig H., Alt, Frederick W.
Publicado em 2013

Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia

Por Boros, Katalin, Puissant, Alexandre, Back, Morgan, Alexe, Gabriela, Bassil, Christopher F., Sinha, Papiya, Tholouli, Eleni, Stegmaier, Kimberly, Byers, Richard J., Rodig, Scott J.
Publicado no Oncotarget (2015)

The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

Por Juszczynski, Przemyslaw, Ouyang, Jing, Monti, Stefano, Rodig, Scott J., Takeyama, Kunihiko, Abramson, Jeremy, Chen, Wen, Kutok, Jeffery L., Rabinovich, Gabriel A., Shipp, Margaret A.
Publicado em 2007

Lipocalin 2 promotes breast cancer progression

Por Yang, Jiang, Bielenberg, Diane R., Rodig, Scott J., Doiron, Robert, Clifton, Matthew C., Kung, Andrew L., Strong, Roland K., Zurakowski, David, Moses, Marsha A.
Publicado em 2009

Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men

Por Bertrand, Kimberly A., Spiegelman, Donna, Aster, Jon C., Altshul, Larisa M., Korrick, Susan A., Rodig, Scott J., Zhang, Shumin M., Kurth, Tobias, Laden, Francine
Publicado em 2010

Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B cell lymphoma distinguishes these tumor types fr...

Por Kondratiev, Svetlana, Duraisamy, Sekhar, Unitt, Christine L., Green, Michael R., Pinkus, Geraldine, Shipp, Margaret A., Kutok, Jeffery L., Drapkin, Ronny I., Rodig, Scott J.
Publicado em 2011

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

Por Kluk, Michael J., Chapuy, Bjoern, Sinha, Papiya, Roy, Alyssa, Cin, Paola Dal, Neuberg, Donna S., Monti, Stefano, Pinkus, Geraldine S., Shipp, Margaret A., Rodig, Scott J.
Publicado em 2012

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

Por Nayak, Lakshmi, Iwamoto, Fabio M., LaCasce, Ann, Mukundan, Srinivasan, Roemer, Margaretha G. M., Chapuy, Bjoern, Armand, Philippe, Rodig, Scott J., Shipp, Margaret A.
Publicado no Blood (2017)

Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis

Por Lovato, Laura, Willis, Simon N., Rodig, Scott J., Caron, Tyler, Almendinger, Stefany E., Howell, Owain W., Reynolds, Richard, O’Connor, Kevin C., Hafler, David A.
Publicado em 2011

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

Por Ott, Christopher J., Kopp, Nadja, Bird, Liat, Paranal, Ronald M., Qi, Jun, Bowman, Teresa, Rodig, Scott J., Kung, Andrew L., Bradner, James E., Weinstock, David M.
Publicado em 2012

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

Por Sander, Sandrine, Calado, Dinis P., Srinivasan, Lakshmi, Köchert, Karl, Zhang, Baochun, Rosolowski, Maciej, Rodig, Scott J., Holzmann, Karlheinz, Stilgenbauer, Stephan, Siebert, Reiner, Bullinger, Lars, Rajewsky, Klaus
Publicado em 2012